Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03389971 · ClinicalTrials.gov registry record · NA
ULTRAsound-assisted Catheter vs. STAndaRd Catheter Thrombolysis for Submassive Pulmonary Embolism
A NA study, sponsored by Piedmont Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03389971 is a NA study that has completed, run by Piedmont Healthcare. The registered enrollment target is 10 participants.
The verdict
NCT03389971, a NA study, has completed, sponsored by Piedmont Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Acute pulmonary embolism (PE) accounts for 5-10% of in-hospital deaths. Systemic anticoagulation (AC) is the standard of care and thrombolysis is recommended for those at a higher mortality risk. Catheter-directed therapies, mainly standard infusion catheter thrombolysis (CDT) and ultrasound-accelerated thrombolysis (USAT), have been introduced as new more effective and safer treatment modalities. USAT is a modification of standard catheter lysis utilizing a system of local ultrasound to dissociate the fibrin matrix of the thrombus with simultaneous acoustic streaming of the thrombolytic agent, allowing more efficient thrombolysis. However, there is limited comparative effectiveness data against standard multi-side hole catheter infusion. More rapid clearance of pulmonary thrombus by USAT compared to standard CDT may prove to be clinically beneficial and cost effective. Alternatively, if thrombus clearance is similar, the cost of USAT may exceed the cost of CDT (equipment and disposables), without realization any advantage.
Interventions
- PROCEDURE catheter-directed thrombolysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-12-06 |
| Est. Completion | 2020-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03389971
The ClinicalTrials.gov registry entry for NCT03389971 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Piedmont Healthcare, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which catheter-directed thrombolysis is the first listed.
NCT03389971 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03389971 about?
NCT03389971 is a clinical study titled "ULTRAsound-assisted Catheter vs. STAndaRd Catheter Thrombolysis for Submassive Pulmonary Embolism". Acute pulmonary embolism (PE) accounts for 5-10% of in-hospital deaths. Systemic anticoagulation (AC) is the standard of care and thrombolysis is recommended for those at a higher mortality risk. Catheter-directed therapies, mainly standard infusion catheter thrombolysis (CDT) and ultrasound-acceler...
What is the current status of trial NCT03389971?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-12-06. Estimated completion is 2020-04-01.
What interventions are being tested in trial NCT03389971?
The interventions under investigation include: catheter-directed thrombolysis (PROCEDURE).
Who is sponsoring clinical trial NCT03389971?
This trial is sponsored by Piedmont Healthcare, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.